PRB1

gene
On this page

Also known as PMPMFPMSPRB1MPRB1L

Summary

PRB1 (proline rich protein BstNI subfamily 1, HGNC:9337) is a protein-coding gene on chromosome 12p13.2, encoding Basic salivary proline-rich protein 1 (P04280).

Predicted to be located in extracellular region.

Source: NCBI Gene 5542 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 123 total

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:9337
Approved symbolPRB1
Nameproline rich protein BstNI subfamily 1
Location12p13.2
Locus typegene with protein product
StatusApproved
AliasesPM, PMF, PMS, PRB1M, PRB1L
Ensembl geneENSG00000251655
Ensembl biotypeprotein_coding
OMIM180989
Entrez5542

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay

ENST00000240636, ENST00000500254, ENST00000545626

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000240636 — 4 exons

ExonStartEnd
ENSE000020342751135307411354002
ENSE000022136141135182311351929
ENSE000022414301135549011355590
ENSE000035082481135451911354554

Expression profiles

Bgee: expression breadth broad, 56 present calls, max score 94.67.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0185 / max 33.9165, expressed in 1 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1296733.28967
1296620.01851

Top tissues by expression

114 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
olfactory segment of nasal mucosaUBERON:000538694.67gold quality
tonsilUBERON:000237265.59gold quality
bone marrowUBERON:000237163.68gold quality
sural nerveUBERON:001548862.64gold quality
bone marrow cellCL:000209262.10silver quality
putamenUBERON:000187459.27gold quality
caudate nucleusUBERON:000187358.95gold quality
nucleus accumbensUBERON:000188256.04gold quality
colonic epitheliumUBERON:000039752.69gold quality
skin of legUBERON:000151149.78gold quality
zone of skinUBERON:000001448.45gold quality
superior frontal gyrusUBERON:000266148.36gold quality
skin of abdomenUBERON:000141646.37gold quality
Ammon’s hornUBERON:000195446.27gold quality
primary visual cortexUBERON:000243646.17gold quality
right frontal lobeUBERON:000281044.41gold quality
dorsolateral prefrontal cortexUBERON:000983442.63gold quality
cerebral cortexUBERON:000095642.45gold quality
anterior cingulate cortexUBERON:000983542.29gold quality
frontal cortexUBERON:000187041.53gold quality
Brodmann (1909) area 9UBERON:001354041.31gold quality
brainUBERON:000095539.85gold quality
granulocyteCL:000009439.26gold quality
prefrontal cortexUBERON:000045139.21gold quality
liverUBERON:000210738.52gold quality
amygdalaUBERON:000187637.37gold quality
temporal lobeUBERON:000187137.27gold quality
skeletal muscle tissueUBERON:000113437.07silver quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.41

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

6 targeting PRB1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-15B-3P97.8566.68974
HSA-MIR-4639-3P97.5467.12787
HSA-MIR-4670-3P97.3768.351378
HSA-MIR-6748-3P97.2065.66836
HSA-MIR-6759-3P96.9468.31823
HSA-MIR-616-3P96.8266.99784

Literature-anchored findings (GeneRIF, showing 1)

  • MP4 and Prb1 in mouse are closely related with the physiology and pathological processes of the ocular surface, and might ontribute to homeostasis of ocular surface or pathogenesis of diseases like dry eye. (PMID:27588265)

Cross-species orthologs

0 orthologs

Paralogs (6): PRR4 (ENSG00000111215), PRB2 (ENSG00000121335), PRH2 (ENSG00000134551), PRB3 (ENSG00000197870), PRB4 (ENSG00000230657), PRH1 (ENSG00000231887)

Protein

Protein identifiers

Basic salivary proline-rich protein 1P04280 (reviewed: P04280)

All UniProt accessions (3): A0A0D9SET1, A0A4W8X8U3, G3V1R1

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Secreted.

Post-translational modifications. O-glycosylated. O-glycosylation on Ser-87 is prevalent in head and neck cancer patients. O-Glycosylation on Ser-330 has a 5 times prevalence in head and neck cancers. Proteolytically cleaved at the tripeptide Xaa-Pro-Gln, where Xaa in the P(3) position is mostly lysine. The endoprotease may be of microbial origin. Pyroglutamate formation occurs on terminal Gln residues of cleaved peptides. Besides on the N-terminal of mature PBR1, pyroglutamate formation found on at least Gln-58.

Polymorphism. The number of repeats is polymorphic and varies among different alleles. The sequence shown is that of allele L (long). There are allele M (medium) and allele S (short) which contain 12 and 9 approximate tandem repeats respectively.

RefSeq proteins (0): (*=MANE)

Domains & families (InterPro)

IDNameType
IPR026086Pro-richFamily

Pfam: PF15240

UniProt features (57 total): repeat 15, sequence conflict 12, compositionally biased region 10, sequence variant 5, chain 4, modified residue 4, glycosylation site 4, region of interest 2, signal peptide 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P04280-F147.260.02

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (4): 17, 40, 92, 150

Glycosylation sites (4): 40, 87, 150, 330

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 27 (showing top): ENK_UV_RESPONSE_KERATINOCYTE_UP, SHEPARD_BMYB_MORPHOLINO_DN, BROWNE_HCMV_INFECTION_6HR_UP, SA_G1_AND_S_PHASES, YOSHIMURA_MAPK8_TARGETS_UP, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS, RAO_BOUND_BY_SALL4_ISOFORM_A, MIR15B_3P, SA_REG_CASCADE_OF_CYCLIN_EXPR, WP_SPINAL_CORD_INJURY, DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS, TRAVAGLINI_LUNG_SEROUS_CELL, WP_PLEURAL_MESOTHELIOMA, GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure1

Protein interactions and networks

STRING

1354 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PRB1PRB4P02813956
PRB1PRH1P02810890
PRB1C4BPAP04003819
PRB1RB1P06400786
PRB1STATHP02808581
PRB1SMR3BP02814513
PRB1X6REF7X6REF7500
PRB1SFTPA2P07714497
PRB1OPRPNP85047453
PRB1IL6RP08887406
PRB1FURINP09958388
PRB1PMF1Q6P1K2377
PRB1A0A087WT04A0A087WT04370
PRB1PRR4Q16378368
PRB1SLC29A4Q7RTT9351

IntAct

2 interactions, top by confidence:

ABTypeScore
GTF2BNME2P1psi-mi:“MI:0914”(association)0.350

BioGRID (25): UBQLN1 (Two-hybrid), PRB1 (Affinity Capture-MS), PRB1 (Reconstituted Complex), PRB1 (Affinity Capture-MS), PRB1 (Positive Genetic), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid)

ESM2 similar proteins: A0A087WUL8, A0A1D9BZF0, B2SU53, F8W0I5, H0YM25, O36421, O46383, P02812, P02849, P02895, P03211, P04280, P04927, P04928, P06916, P08116, P08676, P08726, P09593, P0DPF3, P0DX00, P12027, P13813, P13822, P14708, P16230, P17437, P21850, Q01033, Q01042, Q03400, Q04118, Q1HVF7, Q26005, Q27905, Q3BBV0, Q3KSS4, Q4WW98, Q54G14, Q5MJ10

Diamond homologs: P02810, P02812, P04280, Q04118, Q16378, P10163

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

123 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance112
Likely benign7
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

267 predictions. Top by Δscore:

VariantEffectΔscore
12:11353998:ATTTC:Aacceptor_gain1.0000
12:11353999:TTTC:Tacceptor_gain1.0000
12:11354000:TTC:Tacceptor_gain1.0000
12:11354000:TTCC:Tacceptor_loss1.0000
12:11354001:TC:Tacceptor_gain1.0000
12:11354002:CC:Cacceptor_gain1.0000
12:11354003:C:Aacceptor_loss1.0000
12:11354003:C:CCacceptor_gain1.0000
12:11354003:C:Tacceptor_gain1.0000
12:11354004:T:Cacceptor_loss1.0000
12:11354011:C:CTacceptor_gain1.0000
12:11354012:A:Tacceptor_gain1.0000
12:11353068:TCATA:Tdonor_loss0.9900
12:11353069:CATA:Cdonor_loss0.9900
12:11353070:ATAC:Adonor_loss0.9900
12:11353071:TAC:Tdonor_loss0.9900
12:11353072:ACC:Adonor_loss0.9900
12:11353073:C:Gdonor_loss0.9900
12:11353999:TTTCC:Tacceptor_gain0.9900
12:11354000:TTCCT:Tacceptor_gain0.9900
12:11355486:TTA:Tdonor_loss0.9900
12:11355487:TA:Tdonor_loss0.9900
12:11355489:C:CAdonor_loss0.9900
12:11351926:CTTC:Cacceptor_gain0.9800
12:11354001:TCCT:Tacceptor_gain0.9800
12:11351928:TCCT:Tacceptor_loss0.9700
12:11351929:CCTG:Cacceptor_loss0.9700
12:11351930:C:Aacceptor_loss0.9700
12:11351931:TGAAA:Tacceptor_loss0.9700
12:11354002:CCTG:Cacceptor_gain0.9700

AlphaMissense

927 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1001613411 (12:11355159 A>G), RS1001834186 (12:11356720 G>A), RS1001941977 (12:11356950 G>A,C,T), RS1002501604 (12:11351986 G>A,C), RS1003040034 (12:11354792 C>A), RS1004869310 (12:11355292 C>A,T), RS1005307269 (12:11355684 G>A,C,T), RS1005900671 (12:11354180 A>C), RS1005976583 (12:11351622 G>T), RS1006283943 (12:11353176 A>G,T), RS1006705566 (12:11357423 T>C), RS1009044932 (12:11355871 A>G,T), RS1009353147 (12:11356351 G>A), RS1010132510 (12:11356654 T>C), RS1010720794 (12:11354727 G>A)

Disease associations

OMIM: gene MIM:180989 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

9 total (human), top 9 by PubMed support.

ChemicalActions (top 5)PubMed papers
Resveratroldecreases expression, affects cotreatment1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyreneincreases methylation1
Plant Extractsaffects cotreatment, decreases expression1
Propylthiouracilaffects response to substance1
Silicon Dioxideincreases expression1
Smokedecreases expression1
Zincdecreases expression1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.